Back to the basics: Propolis and COVID ‐19
Article Swipe
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1111/dth.13780
The epidemiological burden of COVID-19 is a healthcare challenge throughout the world, not only in terms of testing the limits of medical capacities, but also as an enigma considering preventive strategies and methods. The upper respiratory tract mucosa is the first line of defense, as a physical barrier, as well as through multiple innate and adaptive immune mechanisms which are crucial for efficient antiviral responses. Identifying methods able to reduce or prevent colonization, viral adhesion, and promote virus shedding on mucous membranes or have the ability to inactivate pathogens and thus reduce virus dose and/or increase immune response would be essential in the management of COVID-19 outbreak and help in flattening the curve. We review the effects of propolis, an old remedy with proven antiviral properties, as a possible low-cost inhibitor of SARS-CoV-2 in the oropharyngeal niche, prophylaxis, or adjuvant therapy.
Related Topics
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1111/dth.13780
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.13780
- OA Status
- bronze
- Cited By
- 65
- References
- 16
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3033741182
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3033741182Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/dth.13780Digital Object Identifier
- Title
-
Back to the basics: Propolis and
COVID ‐19Work title - Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-06-07Full publication date if available
- Authors
-
Dimitri Bachevski, Katerina Damevska, Viktor Simeonovski, Maja DimovaList of authors in order
- Landing page
-
https://doi.org/10.1111/dth.13780Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.13780Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.13780Direct OA link when available
- Concepts
-
Medicine, Immune system, Coronavirus disease 2019 (COVID-19), Adjuvant, Immunology, Propolis, Virus, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Innate immune system, Virology, Disease, Infectious disease (medical specialty), Traditional medicine, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
65Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 4, 2023: 11, 2022: 21, 2021: 19Per-year citation counts (last 5 years)
- References (count)
-
16Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3033741182 |
|---|---|
| doi | https://doi.org/10.1111/dth.13780 |
| ids.doi | https://doi.org/10.1111/dth.13780 |
| ids.mag | 3033741182 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/32506775 |
| ids.openalex | https://openalex.org/W3033741182 |
| fwci | 10.17312777 |
| mesh[0].qualifier_ui | Q000627 |
| mesh[0].descriptor_ui | D000890 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | therapeutic use |
| mesh[0].descriptor_name | Anti-Infective Agents |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000073640 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Betacoronavirus |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D018352 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Coronavirus Infections |
| mesh[4].qualifier_ui | Q000453 |
| mesh[4].descriptor_ui | D018352 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | epidemiology |
| mesh[4].descriptor_name | Coronavirus Infections |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D006801 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Humans |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D058873 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Pandemics |
| mesh[7].qualifier_ui | Q000188 |
| mesh[7].descriptor_ui | D011024 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | drug therapy |
| mesh[7].descriptor_name | Pneumonia, Viral |
| mesh[8].qualifier_ui | Q000453 |
| mesh[8].descriptor_ui | D011024 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | epidemiology |
| mesh[8].descriptor_name | Pneumonia, Viral |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D011429 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Propolis |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D000086402 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | SARS-CoV-2 |
| mesh[11].qualifier_ui | Q000627 |
| mesh[11].descriptor_ui | D000890 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | therapeutic use |
| mesh[11].descriptor_name | Anti-Infective Agents |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000073640 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Betacoronavirus |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000086382 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | COVID-19 |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D018352 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Coronavirus Infections |
| mesh[15].qualifier_ui | Q000453 |
| mesh[15].descriptor_ui | D018352 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | epidemiology |
| mesh[15].descriptor_name | Coronavirus Infections |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D058873 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Pandemics |
| mesh[18].qualifier_ui | Q000188 |
| mesh[18].descriptor_ui | D011024 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | drug therapy |
| mesh[18].descriptor_name | Pneumonia, Viral |
| mesh[19].qualifier_ui | Q000453 |
| mesh[19].descriptor_ui | D011024 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | epidemiology |
| mesh[19].descriptor_name | Pneumonia, Viral |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D011429 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Propolis |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D000086402 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | SARS-CoV-2 |
| type | review |
| title | Back to the basics: Propolis and |
| biblio.issue | 4 |
| biblio.volume | 33 |
| biblio.last_page | e13780 |
| biblio.first_page | e13780 |
| topics[0].id | https://openalex.org/T11386 |
| topics[0].field.id | https://openalex.org/fields/11 |
| topics[0].field.display_name | Agricultural and Biological Sciences |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1109 |
| topics[0].subfield.display_name | Insect Science |
| topics[0].display_name | Bee Products Chemical Analysis |
| topics[1].id | https://openalex.org/T10225 |
| topics[1].field.id | https://openalex.org/fields/11 |
| topics[1].field.display_name | Agricultural and Biological Sciences |
| topics[1].score | 0.9797999858856201 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1106 |
| topics[1].subfield.display_name | Food Science |
| topics[1].display_name | Essential Oils and Antimicrobial Activity |
| topics[2].id | https://openalex.org/T10902 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9581000208854675 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2707 |
| topics[2].subfield.display_name | Complementary and alternative medicine |
| topics[2].display_name | Complementary and Alternative Medicine Studies |
| is_xpac | False |
| apc_list.value | 2500 |
| apc_list.currency | USD |
| apc_list.value_usd | 2500 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7443738579750061 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C8891405 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5607553720474243 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[1].display_name | Immune system |
| concepts[2].id | https://openalex.org/C3008058167 |
| concepts[2].level | 4 |
| concepts[2].score | 0.5211982131004333 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[2].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[3].id | https://openalex.org/C2777863537 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4958246648311615 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q357896 |
| concepts[3].display_name | Adjuvant |
| concepts[4].id | https://openalex.org/C203014093 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4927809536457062 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[4].display_name | Immunology |
| concepts[5].id | https://openalex.org/C2780488879 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4296097755432129 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q184398 |
| concepts[5].display_name | Propolis |
| concepts[6].id | https://openalex.org/C2522874641 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4295693635940552 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q808 |
| concepts[6].display_name | Virus |
| concepts[7].id | https://openalex.org/C3007834351 |
| concepts[7].level | 5 |
| concepts[7].score | 0.425201952457428 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[7].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[8].id | https://openalex.org/C136449434 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4203186333179474 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q428253 |
| concepts[8].display_name | Innate immune system |
| concepts[9].id | https://openalex.org/C159047783 |
| concepts[9].level | 1 |
| concepts[9].score | 0.41286879777908325 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[9].display_name | Virology |
| concepts[10].id | https://openalex.org/C2779134260 |
| concepts[10].level | 2 |
| concepts[10].score | 0.09853166341781616 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[10].display_name | Disease |
| concepts[11].id | https://openalex.org/C524204448 |
| concepts[11].level | 3 |
| concepts[11].score | 0.08747446537017822 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[11].display_name | Infectious disease (medical specialty) |
| concepts[12].id | https://openalex.org/C556039675 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q771035 |
| concepts[12].display_name | Traditional medicine |
| concepts[13].id | https://openalex.org/C142724271 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[13].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7443738579750061 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/immune-system |
| keywords[1].score | 0.5607553720474243 |
| keywords[1].display_name | Immune system |
| keywords[2].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[2].score | 0.5211982131004333 |
| keywords[2].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[3].id | https://openalex.org/keywords/adjuvant |
| keywords[3].score | 0.4958246648311615 |
| keywords[3].display_name | Adjuvant |
| keywords[4].id | https://openalex.org/keywords/immunology |
| keywords[4].score | 0.4927809536457062 |
| keywords[4].display_name | Immunology |
| keywords[5].id | https://openalex.org/keywords/propolis |
| keywords[5].score | 0.4296097755432129 |
| keywords[5].display_name | Propolis |
| keywords[6].id | https://openalex.org/keywords/virus |
| keywords[6].score | 0.4295693635940552 |
| keywords[6].display_name | Virus |
| keywords[7].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[7].score | 0.425201952457428 |
| keywords[7].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[8].id | https://openalex.org/keywords/innate-immune-system |
| keywords[8].score | 0.4203186333179474 |
| keywords[8].display_name | Innate immune system |
| keywords[9].id | https://openalex.org/keywords/virology |
| keywords[9].score | 0.41286879777908325 |
| keywords[9].display_name | Virology |
| keywords[10].id | https://openalex.org/keywords/disease |
| keywords[10].score | 0.09853166341781616 |
| keywords[10].display_name | Disease |
| keywords[11].id | https://openalex.org/keywords/infectious-disease |
| keywords[11].score | 0.08747446537017822 |
| keywords[11].display_name | Infectious disease (medical specialty) |
| language | en |
| locations[0].id | doi:10.1111/dth.13780 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S67424211 |
| locations[0].source.issn | 1396-0296, 1529-8019 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1396-0296 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Dermatologic Therapy |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.13780 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Dermatologic Therapy |
| locations[0].landing_page_url | https://doi.org/10.1111/dth.13780 |
| locations[1].id | pmid:32506775 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Dermatologic therapy |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/32506775 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7300491 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Dermatol Ther |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7300491 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5089436743 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Dimitri Bachevski |
| authorships[0].countries | MK |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I76245029 |
| authorships[0].affiliations[0].raw_affiliation_string | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| authorships[0].institutions[0].id | https://openalex.org/I76245029 |
| authorships[0].institutions[0].ror | https://ror.org/02wk2vx54 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I76245029 |
| authorships[0].institutions[0].country_code | MK |
| authorships[0].institutions[0].display_name | Saints Cyril and Methodius University of Skopje |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Dimitri Bachevski |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| authorships[1].author.id | https://openalex.org/A5049246027 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4745-3747 |
| authorships[1].author.display_name | Katerina Damevska |
| authorships[1].countries | MK |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I76245029 |
| authorships[1].affiliations[0].raw_affiliation_string | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| authorships[1].institutions[0].id | https://openalex.org/I76245029 |
| authorships[1].institutions[0].ror | https://ror.org/02wk2vx54 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I76245029 |
| authorships[1].institutions[0].country_code | MK |
| authorships[1].institutions[0].display_name | Saints Cyril and Methodius University of Skopje |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Katerina Damevska |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| authorships[2].author.id | https://openalex.org/A5044256109 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2956-0928 |
| authorships[2].author.display_name | Viktor Simeonovski |
| authorships[2].countries | MK |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I76245029 |
| authorships[2].affiliations[0].raw_affiliation_string | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| authorships[2].institutions[0].id | https://openalex.org/I76245029 |
| authorships[2].institutions[0].ror | https://ror.org/02wk2vx54 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I76245029 |
| authorships[2].institutions[0].country_code | MK |
| authorships[2].institutions[0].display_name | Saints Cyril and Methodius University of Skopje |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Viktor Simeonovski |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| authorships[3].author.id | https://openalex.org/A5050407964 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9564-3783 |
| authorships[3].author.display_name | Maja Dimova |
| authorships[3].countries | MK |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I76245029 |
| authorships[3].affiliations[0].raw_affiliation_string | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| authorships[3].institutions[0].id | https://openalex.org/I76245029 |
| authorships[3].institutions[0].ror | https://ror.org/02wk2vx54 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I76245029 |
| authorships[3].institutions[0].country_code | MK |
| authorships[3].institutions[0].display_name | Saints Cyril and Methodius University of Skopje |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Maja Dimova |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Faculty of Medicine, University Clinic for Dermatology, Ss. Cyril and Methodius University, Skopje, Macedonia |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.13780 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2020-06-12T00:00:00 |
| display_name | Back to the basics: Propolis and |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11386 |
| primary_topic.field.id | https://openalex.org/fields/11 |
| primary_topic.field.display_name | Agricultural and Biological Sciences |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1109 |
| primary_topic.subfield.display_name | Insect Science |
| primary_topic.display_name | Bee Products Chemical Analysis |
| related_works | https://openalex.org/W1904730247, https://openalex.org/W4405851288, https://openalex.org/W2788391394, https://openalex.org/W2137137814, https://openalex.org/W2164808141, https://openalex.org/W2766623693, https://openalex.org/W2776265622, https://openalex.org/W2001556692, https://openalex.org/W2141268712, https://openalex.org/W2391932356 |
| cited_by_count | 65 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 11 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 21 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 19 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 8 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1111/dth.13780 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S67424211 |
| best_oa_location.source.issn | 1396-0296, 1529-8019 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1396-0296 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Dermatologic Therapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.13780 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Dermatologic Therapy |
| best_oa_location.landing_page_url | https://doi.org/10.1111/dth.13780 |
| primary_location.id | doi:10.1111/dth.13780 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S67424211 |
| primary_location.source.issn | 1396-0296, 1529-8019 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1396-0296 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Dermatologic Therapy |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dth.13780 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Dermatologic Therapy |
| primary_location.landing_page_url | https://doi.org/10.1111/dth.13780 |
| publication_date | 2020-06-07 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W3001897055, https://openalex.org/W3006642361, https://openalex.org/W3013224006, https://openalex.org/W2145181045, https://openalex.org/W1993712342, https://openalex.org/W2796759435, https://openalex.org/W204745572, https://openalex.org/W1573518780, https://openalex.org/W3003839597, https://openalex.org/W2887249132, https://openalex.org/W2051156715, https://openalex.org/W2886423020, https://openalex.org/W2109669101, https://openalex.org/W3015984743, https://openalex.org/W3016333236, https://openalex.org/W3033741182 |
| referenced_works_count | 16 |
| abstract_inverted_index.a | 6, 45, 127 |
| abstract_inverted_index.We | 113 |
| abstract_inverted_index.an | 26, 119 |
| abstract_inverted_index.as | 25, 44, 48, 50, 126 |
| abstract_inverted_index.be | 99 |
| abstract_inverted_index.in | 14, 101, 109, 133 |
| abstract_inverted_index.is | 5, 38 |
| abstract_inverted_index.of | 3, 16, 20, 42, 104, 117, 131 |
| abstract_inverted_index.on | 79 |
| abstract_inverted_index.or | 70, 82, 138 |
| abstract_inverted_index.to | 68, 86 |
| abstract_inverted_index.The | 0, 33 |
| abstract_inverted_index.and | 31, 54, 75, 89, 107 |
| abstract_inverted_index.are | 59 |
| abstract_inverted_index.but | 23 |
| abstract_inverted_index.for | 61 |
| abstract_inverted_index.not | 12 |
| abstract_inverted_index.old | 120 |
| abstract_inverted_index.the | 10, 18, 39, 84, 102, 111, 115, 134 |
| abstract_inverted_index.able | 67 |
| abstract_inverted_index.also | 24 |
| abstract_inverted_index.dose | 93 |
| abstract_inverted_index.have | 83 |
| abstract_inverted_index.help | 108 |
| abstract_inverted_index.line | 41 |
| abstract_inverted_index.only | 13 |
| abstract_inverted_index.thus | 90 |
| abstract_inverted_index.well | 49 |
| abstract_inverted_index.with | 122 |
| abstract_inverted_index.first | 40 |
| abstract_inverted_index.terms | 15 |
| abstract_inverted_index.tract | 36 |
| abstract_inverted_index.upper | 34 |
| abstract_inverted_index.viral | 73 |
| abstract_inverted_index.virus | 77, 92 |
| abstract_inverted_index.which | 58 |
| abstract_inverted_index.would | 98 |
| abstract_inverted_index.and/or | 94 |
| abstract_inverted_index.burden | 2 |
| abstract_inverted_index.curve. | 112 |
| abstract_inverted_index.enigma | 27 |
| abstract_inverted_index.immune | 56, 96 |
| abstract_inverted_index.innate | 53 |
| abstract_inverted_index.limits | 19 |
| abstract_inverted_index.mucosa | 37 |
| abstract_inverted_index.mucous | 80 |
| abstract_inverted_index.niche, | 136 |
| abstract_inverted_index.proven | 123 |
| abstract_inverted_index.reduce | 69, 91 |
| abstract_inverted_index.remedy | 121 |
| abstract_inverted_index.review | 114 |
| abstract_inverted_index.world, | 11 |
| abstract_inverted_index.ability | 85 |
| abstract_inverted_index.crucial | 60 |
| abstract_inverted_index.effects | 116 |
| abstract_inverted_index.medical | 21 |
| abstract_inverted_index.methods | 66 |
| abstract_inverted_index.prevent | 71 |
| abstract_inverted_index.promote | 76 |
| abstract_inverted_index.testing | 17 |
| abstract_inverted_index.through | 51 |
| abstract_inverted_index.COVID-19 | 4, 105 |
| abstract_inverted_index.adaptive | 55 |
| abstract_inverted_index.adjuvant | 139 |
| abstract_inverted_index.barrier, | 47 |
| abstract_inverted_index.defense, | 43 |
| abstract_inverted_index.increase | 95 |
| abstract_inverted_index.low-cost | 129 |
| abstract_inverted_index.methods. | 32 |
| abstract_inverted_index.multiple | 52 |
| abstract_inverted_index.outbreak | 106 |
| abstract_inverted_index.physical | 46 |
| abstract_inverted_index.possible | 128 |
| abstract_inverted_index.response | 97 |
| abstract_inverted_index.shedding | 78 |
| abstract_inverted_index.therapy. | 140 |
| abstract_inverted_index.adhesion, | 74 |
| abstract_inverted_index.antiviral | 63, 124 |
| abstract_inverted_index.challenge | 8 |
| abstract_inverted_index.efficient | 62 |
| abstract_inverted_index.essential | 100 |
| abstract_inverted_index.inhibitor | 130 |
| abstract_inverted_index.membranes | 81 |
| abstract_inverted_index.pathogens | 88 |
| abstract_inverted_index.propolis, | 118 |
| abstract_inverted_index.SARS-CoV-2 | 132 |
| abstract_inverted_index.flattening | 110 |
| abstract_inverted_index.healthcare | 7 |
| abstract_inverted_index.inactivate | 87 |
| abstract_inverted_index.management | 103 |
| abstract_inverted_index.mechanisms | 57 |
| abstract_inverted_index.preventive | 29 |
| abstract_inverted_index.responses. | 64 |
| abstract_inverted_index.strategies | 30 |
| abstract_inverted_index.throughout | 9 |
| abstract_inverted_index.Identifying | 65 |
| abstract_inverted_index.capacities, | 22 |
| abstract_inverted_index.considering | 28 |
| abstract_inverted_index.properties, | 125 |
| abstract_inverted_index.respiratory | 35 |
| abstract_inverted_index.prophylaxis, | 137 |
| abstract_inverted_index.colonization, | 72 |
| abstract_inverted_index.oropharyngeal | 135 |
| abstract_inverted_index.epidemiological | 1 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 95 |
| corresponding_author_ids | https://openalex.org/A5044256109 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I76245029 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.98719478 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |